Chen Xiao-Li, He Jian-Jun, Chen Kan, Lai Bao-Chang, Si Lü-Sheng, Wang Yi-Li
The Key Laboratory of Biomedical Information Engineering of Education Ministry, Institute for Cancer Research, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710061, China.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006 Nov;22(6):748-51.
To observe the distribution of immunocompetent cells (ICCs) in tumor's local draining lymph nodes (LDLN) at different stages of disease including non-metastasis, micro-metastasis and late metastasis.
71 LDLN from 22 breast cancer, 28 LDLN from 7 gastric carcinoma were analysed by using catalyzed signal amplification (CSA) immunohistochemical staining. Monoclonal antibodies (mAbs) to perforin, granzyme B, CD8, CD56, CD68, S-100, CD134 and CD25 were used to detect the amount and functional change of ICCs.
Paracortical hyperplasia and sinus histocytosis was mainly observed in tumor's LDLN. As it was reported, the density of S100(+) dendritic cells (DCs) was decreased as the draining lymph nodes became tumor-containing from the status of tumor free (P<0.05), and the morphology of DCs turned to be inactivated. As the lymph nodes were invaded by tumors, the densities of CD134(+) lymphocytes and CD25(+) cells were significantly increased (P<0.01). Furthermore, there was a significant trend of decreasing in the number of activated cytotoxic T lymphocytes (granzyme B(+) cells) in LDLN as tumor progressed from non/micro-metastasis, early metastasis to advanced stage metastasis (P<0.01). There was no obvious difference in distribution of ICC between non/micro-metastasis sentinel lymph nodes and non-sentinel lymph nodes.
The dynamic change of the ICCs in LDLN implied that immune response of tumor bearing host tends to be inhibited with the progress of tumors.
观察免疫活性细胞(ICCs)在疾病不同阶段(包括无转移、微转移和晚期转移)肿瘤局部引流淋巴结(LDLN)中的分布情况。
采用催化信号放大(CSA)免疫组织化学染色法分析22例乳腺癌患者的71个LDLN以及7例胃癌患者的28个LDLN。使用穿孔素、颗粒酶B、CD8、CD56、CD68、S-100、CD134和CD25的单克隆抗体(mAbs)检测ICCs的数量和功能变化。
肿瘤的LDLN主要表现为副皮质增生和窦组织细胞增生。如报道所示,随着引流淋巴结从无肿瘤状态变为含肿瘤状态,S100(+)树突状细胞(DCs)的密度降低(P<0.05),且DCs的形态转为失活状态。随着淋巴结被肿瘤侵袭,CD134(+)淋巴细胞和CD25(+)细胞的密度显著增加(P<0.01)。此外,随着肿瘤从无转移/微转移、早期转移发展到晚期转移,LDLN中活化的细胞毒性T淋巴细胞(颗粒酶B(+)细胞)数量有显著减少的趋势(P<0.01)。无转移/微转移前哨淋巴结与非前哨淋巴结之间ICCs的分布无明显差异。
LDLN中ICCs的动态变化表明,荷瘤宿主的免疫反应倾向于随着肿瘤进展而受到抑制。